Anti-Müllerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatments

被引:2
|
作者
Reis, Ana Braga [1 ]
Leal, Carla [2 ,3 ,4 ,5 ]
Barreiro, Marcia [2 ,3 ,4 ,5 ]
Tome, Antonio [2 ,4 ]
Vale-Fernandes, Emidio [2 ,3 ,4 ,5 ]
机构
[1] Unidade Local Saude Matosinhos, Unidade Saude Familiar Porta do Sol, Matosinhos, Portugal
[2] Univ Porto, ICBAS, UMIB Unit Multidisciplinary Res Biomed, Sch Med & Biomed Sci, Porto, Portugal
[3] Ctr Procriacao Medicamente Assistida Banco Publ Ga, Ctr Materno Infantil Norte Dr Albino Aroso CMIN, Unidade Local Saude Santo Antonio ULSSA, Porto, Portugal
[4] Ctr Materno Infantil Norte Dr Albino Aroso CMIN, Dept Mulher & Med Reprod, Unidade Local Saude St Antonio ULSSA, Porto, Portugal
[5] Univ Porto, Lab Integrat & Translat Res Populat Hlth, ITR, Porto, Portugal
来源
JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA | 2024年 / 28卷 / 04期
关键词
anti-M & uuml; llerian hormone; in vitro fertilization; intracytoplasmic sperm microinjection; oocytes retrieved; ovarian response; ovarian reserve; ANTI-MULLERIAN HORMONE; OVARIAN RESPONSE; AMH; DEFINITION; BIOMARKERS; WOMEN;
D O I
10.5935/1518-0557.20240049
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the correlation between serum anti-M & uuml;llerian hormone (AMH) and the number of oocytes retrieved after controlled ovarian stimulation for in vitro fertilization treatments and determine cut-off values predictive of poor and high response to stimulation. Methods: It was performed a retrospective observational study that included 1003 cycles of controlled ovarian stimulation carried between February 2017 and December 2023 at a Medically Assisted Procreation Centre. The exclusion criteria were the following: serum AMH levels obtained more than 6 months prior to the start of the ovarian stimulation, the presence of a single ovary, non-Caucasian ethnicity, a controlled ovarian stimulation cycle performed for the purpose of oocyte donation or fertility preservation, a documented diagnosis of endometriosis, a documented history of ovarian surgery and the absence of essential data for the study in the medical records (absence of the number of oocytes obtained or the AMH value). Poor response to stimulation was defined as <= 3 oocytes retrieved, and high response was defined as > 15 oocytes. The correlation between variables was calculated using Spearman's correlation test and cut-off values were determined using ROC (Receiver Operating Characteristic) curves. Results: AMH exhibited a significantly positive correlation with the number of oocytes retrieved (Spearman's correlation coefficient = 0.60, p <0.01). The predictive cut-off for poor ovarian response was 0.72 ng/ mL (specificity of 95.13%, sensitivity of 43.23%), and the predictive cut-off for high ovarian response was 4.77 ng/ mL (specificity of 89.86%, sensitivity of 38.22%). Conclusions: Serum AMH proved to be a good predictor of the ovarian response to controlled ovarian stimulation for in vitro fertilization treatments, which makes it useful in supporting clinical decision-making. However, it should not be used as an absolute discriminator of poor or high ovarian response.
引用
收藏
页码:597 / 603
页数:7
相关论文
共 50 条
  • [31] Serum profile of the anti-müllerian hormone of Nelore bulls in the peripuberty
    Pereira, J. A.
    Satrapa, R. A.
    Gomes, M. G. T.
    Moure, V. R.
    Valdameri, G.
    Kozicki, L. E.
    Sousa, G. C.
    Souza, F. F.
    Laskoski, L. M.
    Souza, F. A.
    ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA, 2024, 76 (03)
  • [32] Anti-Müllerian hormone levels as a predictor of the pregnancy rate in women of advanced reproductive age
    Sezai Sahmay
    Mahmut Oncul
    Abdullah Tuten
    Abdullah Tok
    Abdullah Serdar Acıkgoz
    Ismail Cepni
    Journal of Assisted Reproduction and Genetics, 2014, 31 : 1469 - 1474
  • [33] Anti-Müllerian hormone induces autophagy to preserve the primordial follicle pool in mice
    Lecot-Connan, Tatiana
    Boumerdassi, Yasmine
    Magnin, Francoise
    Binart, Nadine
    Kamenicky, Peter
    Sonigo, Charlotte
    Beau, Isabelle
    FASEB JOURNAL, 2024, 38 (05)
  • [34] Persistent Müllerian duct syndrome: A novel mutation in the Anti-Müllerian Hormone gene
    Ayça Altincik
    Fahri Karaca
    Hüseyin Onay
    Hormones, 2017, 16 : 205 - 208
  • [35] High anti-Müllerian hormone level as a predictor of poor pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection: a retrospective cohort study
    Zhao, Fei
    Wen, Duo
    Zeng, Lin
    Wang, Ruiqi
    Wang, Dingran
    Xu, Huiyu
    Li, Rong
    Chi, Hongbin
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2025, 23 (01)
  • [36] The role of anti-Müllerian hormone testing for fertility prognosis
    Campbell, Mackenzie A.
    BRITISH COLUMBIA MEDICAL JOURNAL, 2024, 66 (09): : 330 - 333
  • [37] Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF
    Pierre Lehmann
    Maria P. Vélez
    Julio Saumet
    Louise Lapensée
    Wael Jamal
    François Bissonnette
    Simon Phillips
    Isaac-Jacques Kadoch
    Journal of Assisted Reproduction and Genetics, 2014, 31 : 493 - 498
  • [38] Associations of bisphenol and phthalate exposure and anti-Müllerian hormone levels in women of reproductive age
    Blaauwendraad, Sophia M.
    Dykgraaf, Ramon H. M.
    Gaillard, Romy
    Liu, Mengling
    Laven, Joop S.
    Jaddoe, Vincent W. V.
    Trasande, Leonardo
    ECLINICALMEDICINE, 2024, 74
  • [39] Anti-Müllerian hormone levels and risk of type 2 diabetes in women
    Renée M. G. Verdiesen
    N. Charlotte Onland-Moret
    Carla H. van Gils
    Rebecca K. Stellato
    Annemieke M. W. Spijkerman
    H. Susan J. Picavet
    Frank J. M. Broekmans
    W. M. Monique Verschuren
    Yvonne T. van der Schouw
    Diabetologia, 2021, 64 : 375 - 384
  • [40] Anti-Müllerian hormone for screening, diagnosis, evaluation, and prediction: A systematic review and expert opinions
    Iwase, Akira
    Asada, Yoshimasa
    Sugishita, Yodo
    Osuka, Satoko
    Kitajima, Michio
    Kawamura, Kazuhiro
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2024, 50 (01) : 15 - 39